As per recent reports, it has been revealed that the Pharmaceutical Benefits Scheme (PBS) has added a heart attack prevention medicine to their list. The drug known as Ticagrelo also known with a name of Brilinta has been added to the list for more than five years from now at the cost of $100 million.
The drug is used to treat myocardial infarction and it is also capable to prevent heart blockage and blood clots and hardening of arteries. It has also been revealed that the Federal Government is also thinking to introduce some other costly medicines.
Medicines to treat leukemia, juvenile arthritis and high blood pressure and bronchitis, tonsillitis and skin infections will be some of the likely additions to the list.
An antibiotic Cefuroxime axetil will also be added to the list and it is also said that medicine to treat arthritis in young patients which is known as Tocilizumab will also be available at subsidized rates.
In addition, the government has decided that they are going to increase prices of 17 medicines, but people who have medic cards need not worry. They will be getting medicines at subsidized prices. Prices of medicines meant to treat reflux, diabetes, high blood pressure, constipation and nausea will be raised.
Health Minister Tanya Plibersek has told that they are going to announce new entrants in the medicine list of the PBS. Medicines for bronchitis, juvenile arthritis, chronic myeloid leukemia, rheumatoid arthritis, blood pressure, and haemodialysis among others will be available at subsidized rate.
Health experts have applauded the decision of the government for adding Brilinta into the PBS list. Experts from Sheffield University said, “Many hospitals in the UK and other countries have not yet introduced ticagrelor because of concerns about higher costs compared to clopidogrel”.